Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131

This information is intended for Colorado Prescribers 

HB 19-1131

MARKETED PRESCRIPTION DRUG COLORADO WAC DISCLOSURE FORM DATE UPDATED
Diabetes Products Form 1/06/2021
Vaccines Form 3/23/2021
ALDURAZYME® (laronidase) Form 1/15/2021
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein] Form 1/06/2021
AUBAGIO® (teriflunomide) Form 1/06/2021
CABLIVI® (caplacizumab-yhdp) Form 1/06/2021
CERDELGA® (eliglustat) capsules, for oral use Form 1/15/2021
Cerezyme® (imiglucerase for injection) Form 1/15/2021
DUPIXENT® (dupilumab) Injection Form 1/06/2021
ELITEK® (rasburicase) for injection Form 1/06/2021
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] Form 1/06/2021
FABRAZYME® (agalsidase beta) for injection, for intravenous use Form 1/15/2021
JEVTANA® (cabazitaxel) Injection Form 1/06/2021
KEVZARA® (sarilumab) Form 1/06/2021
LEMTRADA® (alemtuzumab) Form 1/06/2021
LIBTAYO® (cemiplimab - rwlc) Form 2/01/2021
LOVENOX® (enoxaparin sodium injection)  Form 1/06/2021 
LUMIZYME® (alglucosidase alfa) Form 4/25/2021
Mozobil® (plerixafor injection) Form 1/19/2021
MULTAQ® (dronedarone) Form 5/23/2021
SARCLISA® (isatuximab-irfc) injection Form 1/06/2021
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] Form 1/06/2021
THYROGEN® (thyrotropin alfa for injection) Form 1/15/2021

House Bill 19-1131. Published by the General Assembly of the State of Colorado  

Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Aubagio, Elitek, Jevtana, Kevzara, Lemtrada, LovenoxLumizyme, Multaq, Thymoglobulin